ALPS Medical Breakthroughs ETF
SBIO
#2395
ETF rank
โ‚ฌ0.12 B
Marketcap
๐Ÿ‡บ๐Ÿ‡ธ US
Market
43,83ย โ‚ฌ
Share price
-3.26%
Change (1 day)
61.17%
Change (1 year)

Expense ratio and fees for ALPS Medical Breakthroughs ETF (SBIO)

Gross Expense Ratio

Gross Expense Ratio as of June 2026: 0.5%

Net Expense Ratio

Net Expense Ratio as of June 2026: 0.5%